Case number 1:23-cv-01195
Novo Nordisk Inc. et al v. Meitheal Pharmaceuticals, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 21, 2023 | 13 | STIPULATION AND ORDER OF DISMISSAL (copy to pltf.) CASE CLOSED. Signed by Judge Colm F. Connolly on 12/21/2023. (kmd) (Entered: 12/21/2023) (3) |
| Dec 21, 2023 | 14 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833 B2; 9,265,893 B2. (Attachments: # 1 Stipulation and Order of Dismissal)(kmd) (Entered: 12/21/2023) (0) |
| Dec 20, 2023 | 12 | STIPULATION of Dismissal (without prejudice) - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/20/2023) (3) |
| Dec 18, 2023 | N/A | SO ORDERED, re 11 Unopposed MOTION for Extension of Time to File Answer , move, or otherwise respond to the Complaint in this action to December 22, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Meitheal Pharmaceuticals, Inc. answer due 12/22/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. answer due 12/22/2023. Ordered by Judge Colm F. Connolly on 12/18/2023. (kmd) (Entered: 12/18/2023) (0) |
| Dec 15, 2023 | 11 | Unopposed MOTION for Extension of Time to File Answer , move, or otherwise respond to the Complaint in this action to December 22, 2023 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/15/2023) (4) |
| Nov 14, 2023 | 10 | Unopposed MOTION for Extension of Time to Respond to Complaint (D.I. 1) - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/14/2023) (4) |
| Nov 14, 2023 | N/A | SO ORDERED, re 10 Unopposed MOTION for Extension of Time to Respond to Complaint (D.I. 1), filed by Novo Nordisk A/S, Novo Nordisk Inc. Reset Answer Deadlines: Meitheal Pharmaceuticals, Inc. answer due 12/15/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. answer due 12/15/2023. Ordered by Judge Colm F. Connolly on 11/14/2023. (kmd) (Entered: 11/14/2023) (0) |
| Oct 25, 2023 | N/A | Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (nms) (Entered: 10/25/2023) (0) |
| Oct 25, 2023 | 9 | STANDING ORDER REGARDING BRIEFING IN ALL CASES (nmf) (Entered: 10/25/2023) (2) |
| Oct 24, 2023 | 8 | AFFIDAVIT of Service for Summons, Complaint and related papers served on Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on October 23, 2023, filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) (Entered: 10/24/2023) (10) |
| Oct 23, 2023 | 7 | SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S.Meitheal Pharmaceuticals, Inc. served on 10/23/2023, answer due 11/13/2023. (Egan, Brian) (Entered: 10/23/2023) (2) |
| Oct 20, 2023 | 1 | Complaint* (1) |
| Oct 20, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) (Entered: 10/23/2023) (3) |
| Oct 20, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/08/2023. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 3/8/2026. (vfm) (Entered: 10/23/2023) (1) |
| Oct 20, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,114,833 B2 ;9,265,893 B2. (vfm) (Entered: 10/23/2023) (1) |
| Oct 20, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo Nordisk A/S, Corporate Parent Novo Nordisk US Holdings Inc., Corporate Parent Novo Nordisk Commercial Holdings, Inc. for Novo Nordisk Inc.; Corporate Parent Novo Nordisk Foundation, Corporate Parent Novo Holdings A/S for Novo Nordisk A/S filed by Novo Nordisk A/S, Novo Nordisk Inc.. (vfm) (Entered: 10/23/2023) (2) |
| Oct 20, 2023 | 6 | Summons Issued as to Meitheal Pharmaceuticals, Inc. on 10/20/2023; Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. on 10/20/2023. (Attachments: # 1 Summons Issued) (vfm) (Entered: 10/23/2023) (0) |
